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Introduction
Pheochromocytoma
Pheochromocytoma is a rare neuroendocrine tumor 
derived from chromaffin cells of the sympathoadrenal sys-
tem, with the majority arising in the adrenal medulla1, 2. 
When such tumors arise outside of the adrenal gland, they 
are termed extra-adrenal pheochromocytomas, or para-
gangliomas, and can be located in the abdomen, medias-
tinum, neck, pelvis, organ of Zuckerkandl, and other sites1. 
Pheochromocytomas secrete excessive amounts of cate-
cholamines, leading to rapid rise and fall in blood pres-
sure, headache, sweating and palpitations, but can also 
have very variable and atypical manifestations3, which 
can cause substantial diagnostic difficulties. Because of 
excessive catecholamine secretion, pheochromocytomas 
may precipitate life-threatening hypertension or cardiac 
arrhythmias. These rare tumors are responsible for ap-
proximately 0.5 percent of secondary hypertension4. 
Therefore, if the diagnosis of a pheochromocytoma is over-
looked, the consequences could be disastrous, even fatal4–7. 
Approximately 10 percent of pheochromocytomas and 15 
to 35 percent of paragangliomas are malignant, carrying 
a poor prognosis1. Pheochromocytoma can also be associ-
ated with multiple endocrine neoplasia (MEN) syndromes, 
von Hippel-Lindau disease, nerofibromatosis type 1, Car-
ney–Stratakis syndome, the recently defined paragan-
glioma syndomes type 1, 3 and 4 and others8. To tackle the 
task of correctly diagnosing pheochromocytoma, several 
laboratory tests (the most useful being plasma free meta-
nephrine levels) and imaging techniques (computed to-
mography, magnetic resonance imaging etc.) are being 
used. But after anatomical imaging, functional imaging 
is increasingly being considered as an important and help-
ful diagnostic tool6,9,10. Our presented case report discuss-
es the first experience of using 123I-metaiodobenzylguani-
dine scintigraphy in the diagnosis of pheochromocytoma 
in Croatia and demonstrates the usefulness of this meth-
od in diagnostic evaluation of adrenal gland tumours.
123I- MIBG scintigraphy
123I-metaiodobenzylguanidine (123I- MIBG) is an analog 
of the false neurotransmitter guanethidine and demon-
Coll. Antropol. 43 (2019) 3: 211–216
Case report
From Pulsing Headache to Pheochromocytoma:  
The First Application of 123I-MIBG in the 
Scintigraphy in Croatia – A Case Report
Tatjana Bačun1,2, Aleksandar Kibel1,2, Ivan Mihaljević2,3, Vlado Wagenhofer2,3, Maja Starčević4, Ljubica 
Glavaš-Obrovac2,3
1Internal Medicine Clinic, University Hospital Centre Osijek, Osijek, Croatia
2J. J. Strossmayer University of Osijek, School of Medicine, Osijek, Croatia
3Clinical Institute of Nuclear Medicine and Radiation Protection, University Hospital Centre Osijek, Osijek, Croatia
4Technical School and Secondary Natural School Ruđer Bošković, Osijek, Croatia
A B S T R A C T
This case report presents a patient with pheocromocytoma and the first use of 123I-MIBG scintigraphy in the diagnos-
tic workup of an adrenal gland tumor with elevated metanephrine and normetanephrine levels in Croatia. The patient 
had intensive pulsing headaches for a year. A tumour of the right suprarenal gland has been observed by ultrasound, by 
CT scan, and by MRI of the abdomen. A comprehensive endocrinological observation revealed significantly increased 
values of metanephrine, normetanephrine, epinephrine and noreinephrine. 123I-MIBG scintigraphy excluded multiple 
tumours and metastases of malignant pheochromocytoma. After surgery, diagnosis of pheochromocytoma was proven 
histologically. Three weeks after surgery, the values of metanephrine and normetanephrine were within the normal range.
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strates high uptake both in normal sympathetically in-
nervated tissues (such as the heart and salivary glands) 
and in tumors that express neurohormone transporters 
(neural crest and neuroendocrine tumors) 7. It accumultes 
more rapidly in pheochromocytoma then in normal tissue1. 
123I-MIBG scintigraphy has a sensitivity and specificity 
greater then 90 percent for detection of pheochromocyto-
ma7 and is also very helpful in localizing extraadrenal 
pheochromocytomas and in following patients with malig-
nant tumors1. If uptake of the radiopharmaceutical is low 
or absent in the case of pheocromocytoma, it is highly sug-
gestive for malignancy, but a high accumulation on the 
other hand does not necessarily exclude malignancy1. 123I- 
MIBG is superior in diagnostic imaging compared to 131I-
MIBG because of a shorter half life of 123I, a lower energy 
of the primary imaging photon and a lack of ß-particle 
emission7. This contributes to better imaging quality and 
significantly lower radiation dose.
Clinical Case
The presented patient is a 34-year-old woman, who had 
not been severely ill before the treatment. Family medical 
history included the mother suffering from hypertension 
and the father having elevated cholesterol levels. Personal 
medical history revealed an appendectomy at the age of 6 
years and a left vocal cord polyp surgery 2 years ago. 16 
months before final diagnosis was made, the patient com-
plained about intensive pulsing headaches followed by 
redness and warmth of the face which spread through the 
body. The measured blood pressure was 150/110 mmHg. 
During a period of ten months after this initial presenta-
tion, the patient had no substantial complaints and did not 
measure her blood pressure. However, after this period 
the initial symptoms returned, with palpitations, tachy-
cardia, fine tremor of extremities and general increase in 
sweating. Thyroid gland workup was performed, with nor-
mal results. The patient was examined by an endocrinol-
ogist who recommended further workup, but the patient 
did not comply with this recommendation. She was, among 
others, referred also to a psychiatrist, but declined to con-
sult him.
Three months after that the episodes became more fre-
quent, occasionally up to 2 times /day with blood pressure 
levels of up to 180/110 mmHg, but more often up to 150/110 
mmHg, because of which she was frequently seeking as-
sistance at the Department of emergency medicine. Be-
tween these episodes, blood pressure levels were normal 
(120/80 mmHg). More than a month later, an ultrasonog-
raphy of the abdomen was performed and a round expan-
sive mass was detected in the right liver lobe with dimen-
sions 6.5 x 5 cm, partly hyperechogenic, partly 
anechogenic, compressing the bile bladder. A computed 
tomographic scan (CT) of the abdomen showed an oval 
expansive, partly cystic, formation, with dimensions 6x5 
cm, ranging from the 6th liver segment caudally and occu-
pying the most part of the right suprarenal compartment 
(Figure 1a). The central cystic parts were septate, with 
the outer regions of the solid mass. After applying con-
trast, the outer solid parts of the mass were enhanced, 
whereas the inner cystic regions remained hypodense. The 
possibility of an echinococcal (hydatid) cyst was assumed, 
but excluded by magnetic resonance imaging (MRI). The 
MRI showed an oval, mostly hiperintensive and only mar-
ginally hypointensive zone in the suprarenal area, with 
irregular endoluminal growths (Figure 1b). On post-con-
trast images it was directly enhanced with dimensions 5.4 
x 4.9 cm. Afterwards, the patient was admitted to our 
hospital, a tertiary centre, because of endocrinological 
workup. 
Fig. 1a. CT scan of the abdomen showing an expansive 
formation ranging from the 6th liver segment caudally and 
occupying the most part of the right suprarenal compartment.
Fig. 1b. MRI of the abdomen, showing an oval, mostly hiperin-
tensive and only marginally hypointensive zone in the suprare-
nal area.
 
Fig. 1b. MRI of the abdomen, showing an oval, mostly hiperintensive and only marginally 
hypointensive zone in the suprarenal area. 
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diagnosis of pheochromocytoma. Other endocrinological 
test results were within normal ranges (including chro-
mogranin and neuron specific enolase), the basic labora-
tory parameters and the chest X-ray were normal, and so 
was the CT scan of the chest. 123I-metaiodobenzylguani-
dine scintigraphy (123I- MIBG) was conducted, rerpresent-
ing the first experience of scanning of a neuroendocrino-
logical tumor with the mentioned radiopharmaceutical in 
Croatia and the Clinical Institute of Nuclear Medicine 
and Radiation Protection in University Hospital Centre 
Osijek. The following imaging protocol was used: 1. prep-
aration – thyroid blockade 30 minutes before injection 
(preventing radioiodine uptake in the thyroid); 2. admin-
istration: slow injection (1–2 minutes) of 370 MBq (±10%) 
123I-MIBG; 3. imaging: acquisition at 15 min and 4 h post-
injection, planar images: 128 x 128 matrix, 10 minute 
acquisition, SPECT images: 64 x 64 matrix, 64 frame, 30 
s/slice, 159 keV photopeak (20% window), single head 
camera, LEHR collimator.
The 123I- MIBG accumulation was detectable in the 
area of the right suprarenal gland, confirming the exist-
ence of pheochromocytoma. Figure 2a shows a selected 
image of the pathological radiopharmaceutical accumula-
tions, and Figure 2b shows the SPECT imaging from dif-
ferent angles.
After adequate preparation, the values of metaneph-
rine, normetanephrine, epinephrine, noreinephrine and 
vanillylmandelic acid (VMA) were significantly elevated 
(with the levels of metanephrine and normetanephrine 
more than 12 times above normal), which suggested the 
 
 
Fig. 2a. Adrenal gland scintigraphy using 123I-MIBG. Pathological accumulation of activity  
from the 3rd liver segment through porta hepatis to the caudal, oval shap d, ot quite 












Fig. 2a. Adrenal gland scintigraphy using 123I-MIBG. 
Pathological accumulation of activity from the 3rd liver 
segment through porta hepatis to the caudal, oval shaped, not 
quite homogeneous aggregation, with “cold” areas - may 
ind cate the presence of heochromocytoma. 
Fig. 2b. Adrenal gland scintigraphy using 123I-MIBG. Sequence of SPECT images.
Fig. 2b. Adrenal gland scintigraphy using 123I-MIBG. Sequence of SPECT images.
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During preoperative treatment, α- and β-adrenergic 
blockade (fenoxybenzamine and bisoprolol) was included 
to control blood pressure and to prevent hypertensive cri-
ses. On the second day, patient was encouraged to start a 
diet high in sodium content (5 g daily) to expand the con-
tracted blood volume. During hospitalization, the patient 
had frequent attacks with the blood pressure up to 180/95 
mmHg; after the introduction of alpha blockade, during 
the attacks the values did not go higher than 150/90 
mmHg, while between the attacks the values were in the 
range 100–120/70–80 mmHg. She was surgically treated 
at the Urology Clinic of University Hospital Centre Za-
greb. Diagnosis of pheochromocytoma was confirmed his-
tologically, and removed lymph nodes from the abdomen 
were histologically normal. Three weeks after surgery, the 
values of metanephrine and normetanephrine were with-
in normal limits. The patient was feeling well. She re-
turned to work one month after the operation. It is planned 
to monitor the values of metanephrine and normetaneph-
rine once a year during the next 10 years. Genetic testing 
for RET proto-oncogene mutations is under way.
Conclusion
123I-MIBG scintigraphy proved to be a useful method 
in the diagnosis of pheochromocytoma in our presented 
case. It confirmed that the adrenal gland tumour in ques-
tion accumulated the radiopharmaceutical and was indeed 
a pheochromocytoma, as suspected on the basis of bio-
chemical tests and a visible suprarenal mass with a diam-
eter of approximately 6 cm. This was at the same time the 
first performed 123I-MIBG scintigraphy in the Clinical 
Institute of Nuclear Medicine and Radiation Protection, 
University Hospital Centre Osijek, to confirm pheochro-
mocytoma developed in a 34-year-old woman. This meth-
od is not only relevant in confirming suspicious masses of 
the adrenal glands, but can also be important in localizing 
tumour tissue outside of the adrenal glands (paraganglio-
mas), as well as in determining metastases of pheochro-
mocytoma, which would confirm malignancy. In fact, it 
may be quite important to differentiate paraganglioma 
from adrenal gland pheochromocytoma (not feasible based 
on biochemical testing), since recent analyses suggest dif-
ferences in genetic mutations, invasiveness and therapy 
for the two tumour variants11. 
After the proper diagnostic algorithm was implement-
ed and the diagnosis confirmed, the patient was treated 
successfully, with the values of metanephrine and 
normetanephrine reaching the normal range three weeks 
after surgery. She has been monitored since for possible 
recurrence of the disease or for possible proto-oncogene 
mutations. The role of 123I-MIBG scintigraphy may as 
well prove to be relevant for the follow-up of the patient, 
although the exact frequency of scans remains to be dis-
cussed. 
This case report is also interesting because of the fact 
that the patient was having pulsing headaches with no 
clear cause recognized in the beginning. She had symp-
toms over a long period of time and was referred to vari-
ous specialists and diagnostic procedures without receiv-
ing a conclusive diagnosis early in the workup process. 
It is an example that in cases of headaches, especially if 
diverse or unclear additional symptoms are associated 
with it, a clinician should always take a possible pheo-
chromocytoma into consideration. The question of includ-
ing metanephrine and normetanephrine tests into stan-
dard guidelines for headache diagnosis and workup 
should perhaps be evaluated in the future.
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OD PULSIRAJUĆE GLAVOBOLJE DO FEOKROMOCITOMA: PRVA SCINTIGRAFIJA PRIMJENOM 
123I-MIBG U HRVATSKOJ – PRIKAZ SLUČAJA
S A Ž E T A K
Prikazana je bolesnica s feokromocitom i prva scintigrafija primjenom 123I-MIBG u našoj ustanovi i u Hrvatskoj u 
dijagnostičkoj obradi tumora nadbubrežne žlijezde s povišenim vrijednostima metanefrina i normetanefrina. Bolesnica 
je godinu dana imala intenzivne pulsirajuće glavobolje. Ultrazvukom, CT-om i MR-om trbuha utvrđen je tumor desne 
nadbubrežne žlijezde. Opsežnom endokrinološkom obradom utvrđene su povišene vrijednosti metanefrina, normetane-
frina, adrenalina i noradrenalina. Scintigrafijom 123I-MIBG isključeni su multipli tumori i metastaze malignog feokro-
mocitoma. Nakon operacije, dijagnoza feokromocitoma potvrđena je histološki. Tri tjedna nakon operativnog zahvata, 
vrijednosti metanefrina i normetanefrina bile su uredne.

